IMPEDIMED TECHNOLOGY BACKED BY NEW STUDY

Written on the 14 September 2016 by James Perkins

IMPEDIMED TECHNOLOGY BACKED BY NEW STUDY A STUDY has found that Brisbane-based company ImpediMed's (ASX: IPD) L-Dex technology (pictured) is effective in monitoring patients that are at-risk of breast cancer related lymphoedema.

The study, conducted in the United States and published in the journal Frontiers in Oncology, reported that 326 patients were monitored with the L-Dex technology  post axillary lymph node dissection (ALND) or sentinel lymph node biopsy (SLNB).

Through monitoring fluid status and body composition through bioimpedance spectroscopy, L-Dex allowed for early intervention for patients who showed further incidence of sub-clinical lymphoedema after undergoing either an ALND or SLNB and allowed reduction in the persistence of this condition by 99.5 per cent for ALND patients and 91.4 per cent for SLNB patients.

The study concluded, "The results of this retrospective study demonstrate that L-Dex assessments can be incorporated into routine breast cancer programs as part of follow-up."

The researchers, from Texas, noted that this was critically important, given new health guidelines in the US for monitoring the post-treatment follow-up care of for breast cancer patients.

"As we await the results of the post-approval L-Dex study currently underway, we are pleased at the publication of these important and positive clinical data for L-Dex," says Richard Carreon, ImpediMed Managing Director and CEO in a statement to the ASX today.

L-Dex was developed by Associate Professor Leigh Ward from the University of Queensland.

IPD is trading up 6.55 per cent on the ASX this morning, at $3.94 per share.



Author: James Perkins Connect via: Twitter LinkedIn

Latest News

SPOTLESS REJECTS DOWNER'S 'HOSTILE' $1.2B BID AS IT PROMISES A STRATEGY RESET

CLEANING and catering services company Spotless has rejected a $1.26 billion takeover bid from mining services firm D...

EXCLUSIVE INTERVIEW: MEGAPORT CEO VINCENT ENGLISH ON GLOBAL EXPANSION AND HOW TO SCALE UP A BUSINESS

THE RAPID expansion of Megaport (ASX: MP1) continues with the Brisbane-based company announcing a major partnership d...

BRISBANE ENTREPRENEUR BREAKS BARRIERS IN ECO-BUSINESS

TRACEY Bailey believes that if every person understood the true social and environmental cost of every product the...

DOMINO'S PIZZA EMPLOYEES OFFERED A SLICE OF THE PIE

DOMINO'S Pizza (ASX: DMP) has launched an employee share acquisition plan which will give its 26,000 staff the...

Related News

FURNITURE DISRUPTOR SET TO SHARE HIS ONE OF A KIND BUSINESS MODEL

IT'S no secret that Australians love homemaking. Their ceaseless quest to create the perfect place to call hom...

WEEDING OUT THE ASX'S BURGEONING CANNABIS TREND: 8 COMPANIES TO WATCH

A NICHE is budding on the ASX in the form of medical cannabis, an industry which has been on the country's rad...

FRESH CLASS ACTION TO REVEAL ANOTHER SIDE OF SLATER AND GORDON DOWNFALL

ACA LAWYERS has issued a formal letter of demand to Andrew Grech (pictured), managing director of Slater and Gordo...

STARSHIPS WERE MEANT TO DELIVER DOMINO'S PIZZA

NICKI Minaj may have been off the mark when she declared 'starships were meant to fly'. However, she m...

EVENTS COMING UP

 

Contact us

Email News Update Sign Up Contact Details
Subscriptions

PO Box 2087
Brisbane QLD 4001

LoginTell a FriendSign Up to Newsletter